Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01589601 · ClinicalTrials.gov registry record · NA

Palliative Care in Heart Failure

A NA study, sponsored by Duke University.

Completed
Registry status
NA
Development phase
150
Enrollment target

NCT01589601: Completed NA study, sponsored by Duke University.

NCT01589601 is a NA study that has completed, run by Duke University. The registered enrollment target is 150 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01589601, a NA study, has completed, sponsored by Duke University.

COMPLETED
Registry status
NA
Development phase
150 participants
Enrollment target

Study Summary

The primary aim of the PAL-HF trial is to assess the impact of an interdisciplinary palliative care intervention combined with usual heart failure management on health-related quality of life as measured by the Kansas City Cardiomyopathy Questionnaire and the Functional Assessment of Chronic Illness Therapy with Palliative Care Subscale.

Primary Outcome

The primary endpoint is health-related quality of life as measured by the Kansas City Cardiomyopathy Questionnaire (KCCQ). The KCCQ is a 23-item, disease-specific questionnaire scored from 0-100 with high scores representing better health status.

Interventions

  • BEHAVIORAL Usual heart failure care
  • BEHAVIORAL Interdisciplinary palliative care

Trial Details

FieldValue
Enrollment Target 150 participants
Start Date 2012-08
Est. Completion 2016-02
Phase NA
Duke University

1,725 total trials

What the finished NCT01589601 record still lists

NCT01589601 is an interventional study that assigns participants to a tested intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower).

The record links to 0 conditions, and to 2 interventions - of which Usual heart failure care is the first listed.

NCT01589601 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01589601 about?

NCT01589601 is a clinical study titled "Palliative Care in Heart Failure". The primary aim of the PAL-HF trial is to assess the impact of an interdisciplinary palliative care intervention combined with usual heart failure management on health-related quality of life as measured by the Kansas City Cardiomyopathy Questionnaire and the Functional Assessment of Chronic Illness...

What is the current status of trial NCT01589601?

This trial is currently completed. It is a NA study. The enrollment target is 150 participants. The study started on 2012-08. Estimated completion is 2016-02.

What interventions are being tested in trial NCT01589601?

The interventions under investigation include: Usual heart failure care (BEHAVIORAL), Interdisciplinary palliative care (BEHAVIORAL).

Who is sponsoring clinical trial NCT01589601?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01589601's enrollment target sits among peer trials

150 661st of 2000 higher than 1,299 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00412594 · 150 participants · Phase 2

    Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia

  • NCT01484730 · 150 participants

    A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion

  • NCT01985919 · 150 participants

    Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples

  • NCT02016248 · 150 participants · NA

    SBRT Boost for Unfavorable Prostate Cancer'

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01589601, the US trial registry maintained by the National Library of Medicine. NCT01589601 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.